Mitochondrial diseases 2018, progress in research and treatment

Authors

  • Ewa Bartnik Institute of Genetics and Biotechnology Faculty of Biology, University of Warsaw
  • Katarzyna Tońska Institute of Genetics and Biotechnology Faculty of Biology, University of Warsaw
  • Joanna Rusecka Institute of Genetics and Biotechnology Faculty of Biology, University of Warsaw

DOI:

https://doi.org/10.18388/pb.2018_143

Abstract

Mitochondrial diseases are caused by dysfunction of the mitochondrial oxidative phosphorylation system and can be the result of mutations both in mitochondrial DNA and in nuclear DNA. Mitochondrial diseases collectively describe a diverse group of heritable disorders, which may present at any age and have a wide spectrum of clinical manifestations. This leads to highly variable presentations, making the diagnosis of mitochondrial diseases challenging. Recent advances in genetic testing and novel reproductive options hold great promise for improving the clinical identification and treatment of mitochondrial diseases. In this work we discuss what is new in  understanding and diagnosis of mitochondrial diseases.

Downloads

Download data is not yet available.

Downloads

Published

2018-12-29

Issue

Vol. 64 No. 4 (2018): Rare diseases special issue

Section

Articles

License

All journal contents are distributed under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license. Everybody may use the content following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made, ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. There are no additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Copyright for all published papers © stays with the authors.

Copyright for the journal: © Polish Biochemical Society.